Evidence map›Paper›PMID 37790286›Full record

ArticleMaterials today (Kidlington, England)

3D Printed Materials for Combating Antimicrobial Resistance.

Mert Tunca Doganay, Cyril John Chelliah, Abdullah Tozluyurt, Andrea M Hujer, Stephen K Obaro, Umut Gurkan, Robin Patel, Robert A Bonomo, Mohamed Draz

Open access · greenAbstract read
In one paragraph

Article in Materials today (Kidlington, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Mert Tunca DoganayDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Cyril John ChelliahDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Abdullah TozluyurtDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Andrea M HujerDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Stephen K ObaroUniversity of Nebraska Medical Center, Omaha, NE 68198, USA.
Umut GurkanMechanical and Aerospace Engineering Department, Case Western Reserve University, Cleveland, Ohio, USA.
Robin PatelDivision of Clinical Microbiology, Department of Laboratory Medicine and Pathology and Division of Public Health, Infectious Diseases, and Occupational medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Robert A BonomoDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Mohamed DrazDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
University School · USLouis Stokes Cleveland VA Medical Center · USCase Western Reserve University · USCleveland Clinic · USMayo Clinic · USUniversity of Nebraska Medical Center · US

Funding

Combatting AntiMicrobial Resistance in Africa Using Data Science (CAMRA)U54TW012056 · FIC · REDEEMER'S UNIVERSITY · PI Derrick E Fouts, Christian T. Happi · 2021 to 2026
$6.7M
FIC NIH HHS U54 TW012056
6 · The paper itself

Abstract

Three-dimensional (3D) printing is a rapidly growing technology with a significant capacity for translational applications in both biology and medicine. 3D-printed living and non-living materials are being widely tested as a potential replacement for conventional solutions for testing and combating antimicrobial resistance (AMR). The precise control of cells and their microenvironment, while simulating the complexity and dynamics of an

Indexed as

3D printingantibioticantibiotic deliveryantibiotic testingantimicrobial resistancebacteriabioprinting

Identifiers

PMID37790286
PMCPMC10545363
OpenAlexW4381194950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.